by Danielle Bonadies | Jan 6, 2022 | News
On January 1, The New York Times published an article, “When They Warn of Rare Disorders, These Prenatal Tests Are Usually Wrong,” followed by a discussion with the author on their popular podcast, The Daily, entitled, “An Investigation into Flawed...
by Danielle Bonadies | Dec 22, 2021 | Genetic Testing Challenges in Oncology, News
A woman in her 20s was concerned about her risk for breast cancer because her mother had previously had it. She saw a medical oncologist and wanted to be tested to see if she had inherited any pathogenic genetic variants that could increase her risk for developing...
by Danielle Bonadies | Nov 29, 2021 | Genetic Testing Challenges in Oncology, News
A 44-year-old woman with breast cancer came to see a surgeon to discuss risk-reducing surgical options. Three years earlier, she had also been diagnosed with papillary thyroid cancer. Now, because of her breast cancer diagnosis, the patient had come from a small,...
by Danielle Bonadies | Nov 5, 2021 | News
The leading healthcare and precision medicine companies are focused on commercial growth that relies on genome-driven personalization of healthcare, and for that, they are turning to digital health technology companies. The race to build a comprehensive suite of...
by Danielle Bonadies | Oct 29, 2021 | Genetic Journal, News
For some, it may seem like certain types of cancers “run in the family.” This can be due to shared behaviors or exposures that increase cancer risk, or an abnormal genetic change that’s passed down from generation to generation. Over the past 25...
